Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial.
Ana Castro-BaladoIgnacio Novo-VeleiroNéstor Vázquez-AgraGema Barbeito-CastiñeirasAna Estany-GestalRocío TrastoyMiguel González-BarciaIrene Zarra-FerroMaría Carmen Del Río-GarmaCarlos Crespo-DizOlga Delgado-SánchezFrancisco-Javier Otero-EspinarCristina Mondelo-GarcíaAntonio Pose-ReinoAnxo Fernandez-FerreiroPublished in: Pharmaceutics (2023)
The efficacy of inhaled ethanol in terms of the progression of SARS-CoV-2 infection was not demonstrated in the present trial. However, it is positioned as a safe treatment for elderly patients with early-stage COVID-19.
Keyphrases
- phase ii
- early stage
- clinical trial
- open label
- respiratory syndrome coronavirus
- phase iii
- double blind
- sars cov
- coronavirus disease
- cystic fibrosis
- placebo controlled
- study protocol
- middle aged
- squamous cell carcinoma
- randomized controlled trial
- combination therapy
- radiation therapy
- community dwelling
- replacement therapy